Cargando…

Immunohistochemical characteristics of basal-like breast cancer

Basal-like breast cancer (BLBC) occurs mainly in young patients. It is characterized by an aggressive clinical outcome, presence of distant metastases, particularly within the first five years of the disease, bad prognosis and relatively high mortality. Recently greater interest of scientists in thi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Badowska-Kozakiewicz, Anna M., Budzik, Michał P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2017
Materias:	Review Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5320452/ https://www.ncbi.nlm.nih.gov/pubmed/28239279 http://dx.doi.org/10.5114/wo.2016.56938

Ejemplares similares

Histopathological analysis of mucinous breast cancer subtypes and comparison with invasive carcinoma of no special type
por: Budzik, Michał Piotr, et al.
Publicado: (2021)

The role of oestrogen and progesterone receptors in breast cancer – immunohistochemical evaluation of oestrogen and progesterone receptor expression in invasive breast cancer in women
por: Badowska-Kozakiewicz, Anna M., et al.
Publicado: (2015)

Selected tumor markers in the routine diagnosis of chromophobe renal cell carcinoma
por: Badowska-Kozakiewicz, Anna M., et al.
Publicado: (2016)

Medullary breast cancer is a predominantly triple-negative breast cancer – histopathological analysis and comparison with invasive ductal breast cancer
por: Budzik, Michał P., et al.
Publicado: (2019)

Immunohistochemical evaluation of human epidermal growth factor receptor 2 and estrogen and progesterone receptors in invasive breast cancer in women
por: Badowska-Kozakiewicz, Anna M., et al.
Publicado: (2012)

Clinicopathological factors associated with novel prognostic markers for patients with triple negative breast cancer
por: Badowska-Kozakiewicz, Anna M., et al.
Publicado: (2018)

Assessment of Pain, Acceptance of the Disease, Adaptation to Life and Strategies for Coping with the Disease among Patients with Ovarian Cancer
por: Religioni, Urszula, et al.
Publicado: (2021)

Rare Non-Neuroendocrine Pancreatic Tumours
por: Mormul, Agata, et al.
Publicado: (2023)

Pulmonary blastoma in a pregnant woman: a case report and brief review of the literature
por: Budzik, Michał P., et al.
Publicado: (2022)

Current State of Knowledge on the Immune Checkpoint Inhibitors in Triple-Negative Breast Cancer Treatment: Approaches, Efficacy, and Challenges
por: Uchimiak, Katarzyna, et al.
Publicado: (2022)

The complexity of tumour angiogenesis based on recently described molecules
por: Wiśniewska, Weronika, et al.
Publicado: (2021)

Retrospective evaluation of histopathological examinations in invasive ductal breast cancer of no special type: an analysis of 691 patients
por: Badowska-Kozakiewicz, Anna M., et al.
Publicado: (2016)

Expression of multidrug resistance protein P-glycoprotein in correlation with markers of hypoxia (HIF-1α, EPO, EPO-R) in invasive breast cancer with metastasis to lymph nodes
por: Badowska-Kozakiewicz, Anna M., et al.
Publicado: (2016)

What is new about ovarian malignancies?
por: Grabska, Kinga, et al.
Publicado: (2021)

Biomarkers for Basal-like Breast Cancer
por: Choo, Jennifer R., et al.
Publicado: (2010)

The SOX11 transcription factor is a critical regulator of basal-like breast cancer growth, invasion, and basal-like gene expression
por: Shepherd, Jonathan H., et al.
Publicado: (2016)

Heterogeneity of luminal breast cancer characterised by immunohistochemical expression of basal markers
por: Sung, Hyuna, et al.
Publicado: (2016)

Cancer-associated inflammation: pathophysiology and clinical significance
por: Pęczek, Piotr, et al.
Publicado: (2022)

Identification and evaluation of network modules for the prognosis of basal-like breast cancer
por: Hallett, Robin M., et al.
Publicado: (2015)

The Proliferative and Apoptotic Landscape of Basal-like Breast Cancer
por: Alexandrou, Sarah, et al.
Publicado: (2019)

Assessment of Pain, Acceptance of Illness, Adjustment to Life, and Strategies of Coping with Illness among Patients with Gastric Cancer
por: Religioni, Urszula, et al.
Publicado: (2019)

Morphological and pathological features of basal-like breast cancer
por: Botti, Gerardo, et al.
Publicado: (2019)

New Treatment Options in Metastatic Pancreatic Cancer
por: Fudalej, Marta, et al.
Publicado: (2023)

FOXC1 identifies basal-like breast cancer in a hereditary breast cancer cohort
por: Johnson, Jeff, et al.
Publicado: (2016)

Evaluation of Nutritional Status and the Impact of Nutritional Treatment in Patients with Pancreatic Cancer
por: Mękal, Dominika, et al.
Publicado: (2023)

Are Basal-Like and Non-Basal-Like Triple-Negative Breast Cancers Really Different?
por: Dogra, Atika, et al.
Publicado: (2020)

Comparative analysis of clinicopathological characteristics of central necrotizing breast cancer and basal cell-like breast cancer
por: Ding, Li, et al.
Publicado: (2023)

The Epithelial-to-Mesenchymal Transition in Breast Cancer: Focus on Basal-Like Carcinomas
por: Fedele, Monica, et al.
Publicado: (2017)

Immunohistochemical Subtypes of The Breast Cancer in The Ultrasound and Clinical Aspect – Literature Review
por: Dobruch-Sobczak, Katarzyna, et al.
Publicado: (2022)

The Met oncogene and basal-like breast cancer: another culprit to watch out for?
por: Gastaldi, Stefania, et al.
Publicado: (2010)

Meta-Analysis of the Luminal and Basal Subtypes of Bladder Cancer and the Identification of Signature Immunohistochemical Markers for Clinical Use
por: Dadhania, Vipulkumar, et al.
Publicado: (2016)

Unraveling the complexity of basal-like breast cancer
por: Marotta, Lauren L. C., et al.
Publicado: (2011)

How A Patient with Resectable or Borderline Resectable Pancreatic Cancer should Be Treated—A Comprehensive Review
por: Kwaśniewska, Daria, et al.
Publicado: (2023)

The Epigenetics of Triple-Negative and Basal-Like Breast Cancer: Current Knowledge
por: Temian, Daiana Cosmina, et al.
Publicado: (2018)

Epigenetic activation of HORMAD1 in basal-like breast cancer: role in Rucaparib sensitivity
por: Wang, Xian, et al.
Publicado: (2018)

Inhibition of super enhancer downregulates the expression of KLF5 in basal-like breast cancers
por: Chen, Chuan-Huizi, et al.
Publicado: (2019)

Twist promotes tumor metastasis in basal-like breast cancer by transcriptionally upregulating ROR1
por: Cao, Jingying, et al.
Publicado: (2018)

miRNA-135b Contributes to Triple Negative Breast Cancer Molecular Heterogeneity: Different Expression Profile in Basal-like Versus non-Basal-like Phenotypes
por: Uva, Paolo, et al.
Publicado: (2018)

Primary breast mucinous cystadenocarcinoma—histopathological analysis
por: Budzik, Michał Piotr
Publicado: (2023)

Triple-negative breast cancer with brain metastases: a comparison between basal-like and non-basal-like biological subtypes
por: Niwińska, Anna, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_4d0i7obus9kh4q70tp2fap0ke9